← Back to News

Various

Analyst Upgrades and Downgrades For the Week of October 21st

Analyst upgrades, downgrades, and more

By Justin Nugent · October 21, 2024
Analyst Upgrades and Downgrades For the Week of October 21st

October 25th

Upgrades:

  • Air Products (APD): Redburn Atlantic upgraded from Sell to Neutral, Price Target $330.
  • Denny’s (DENN): Citigroup upgraded from Neutral to Buy, Price Target raised from $7 to $7.5.
  • Taylor Morrison Home (TMHC): Wedbush upgraded from Neutral to Outperform, Price Target $85.
  • Toll Brothers (TOL): Wedbush upgraded from Neutral to Outperform, Price Target $175.
  • TC Energy (TRP): Morgan Stanley upgraded from Underweight to Overweight.
  • Volvo (VLVLY): UBS upgraded from Sell to Neutral.
  • Element Solutions (ESI): Wolfe Research upgraded from Peer Perform to Outperform.
  • Annovis Bio (ANVS): Maxim Group upgraded from Hold to Buy, Price Target $25.
  • Baker Hughes (BKR): Argus upgraded from Hold to Buy.
  • Ryanair Hldgs (RYAAY): Barclays upgraded from Equal Weight to Overweight.
  • Summit Materials (SUM): RBC Capital Markets upgraded from Sector Perform to Outperform, Price Target raised from $45 to $53.

Downgrades:

  • Apple (AAPL): KeyBanc Capital Markets downgraded from Sector Weight to Underweight, Price Target $200.
  • Alexandria RE (ARE): RBC Capital Markets downgraded from Outperform to Sector Perform, Price Target lowered from $130 to $125.
  • Bristol-Myers (BMY): Citigroup downgraded from Buy to Neutral, Price Target lowered from $75 to $55.
  • Beyond, Inc. (BYON): BofA Securities downgraded from Neutral to Underperform, Price Target lowered from $12.5 to $6.
  • Honeywell (HON): Robert W. Baird downgraded from Outperform to Neutral, Price Target lowered from $223 to $217.
  • Kraft Heinz (KHC): Stifel downgraded from Buy to Hold, Price Target lowered from $40 to $38.
  • Plains All American (PAA): Morgan Stanley downgraded from Overweight to Equal-Weight, Price Target lowered from $22 to $19.
  • Plains GP (PAGP): Morgan Stanley downgraded from Overweight to Equal-Weight, Price Target lowered from $22 to $19.
  • Rexford Industrial Realty (REXR): Scotiabank downgraded from Sector Outperform to Sector Perform, Price Target lowered from $55 to $48.
  • Boston Beer Co (SAM): Jefferies downgraded from Buy to Hold, Price Target lowered from $355 to $325.
  • J.M. Smucker (SJM): Stifel downgraded from Buy to Hold, Price Target lowered from $135 to $125.
  • Teck Resources (TECK): Deutsche Bank downgraded from Buy to Hold, Price Target not specified.
  • T-Mobile US (TMUS): Raymond James downgraded from Outperform to Market Perform.
  • Western Midstream (WES): Morgan Stanley downgraded from Equal-Weight to Underweight, Price Target lowered from $42 to $40.
  • World Kinect Corporation (WKC): Stifel downgraded from Buy to Hold, Price Target lowered from $33 to $32.
  • Newmont Corporation (NEM): Scotiabank downgraded from Sector Outperform to Sector Perform.
  • Boot Barn Holdings (BOOT): Craig Hallum downgraded from Buy to Hold, Price Target raised from $154 to $162.

Coverage Initiated:

  • Apellis Pharmaceuticals (APLS): RBC Capital Markets initiated with Sector Perform, Price Target $25.
  • BKV Corporation (BKV): Truist initiated with Buy, Price Target $24.
  • Builders FirstSource (BLDR): UBS initiated with Buy, Price Target $232.
  • Lyft (LYFT): The Benchmark Company initiated with Hold.
  • National Energy Services Reunited (NESR): BTIG Research initiated with Buy, Price Target $15.
  • PPL Corp (PPL): JP Morgan initiated with Overweight, Price Target $37.
  • Uber (UBER): The Benchmark Company initiated with Hold.
  • Waldencast plc (WALD): Canaccord Genuity initiated with Buy, Price Target $5.
  • Regency Centers (REG): KeyBanc Capital Markets initiated with Overweight, Price Target $80.
  • South Bow Corporation (SOBO): Morgan Stanley initiated with Underweight.
  • TriSalus Life Sciences (TLSI): Northland Capital initiated with Outperform, Price Target $12.5.

October 24th

Upgrades

  • Hanmi Financial (HAFC): Piper Sandler upgraded from Neutral to Overweight, price target raised from $20 to $25.5.
  • NextEra Energy Partners (NEP): JP Morgan upgraded from Underweight to Neutral, price target lowered from $25 to $22.
  • Steris (STE): Piper Sandler upgraded from Neutral to Overweight, price target increased from $230 to $260.
  • UP Fintech (TIGR): China Renaissance upgraded from Hold to Buy.
  • Regions Financial (RF):
    • Deutsche Bank upgraded from Hold to Buy, price target raised from $24 to $26.
    • Argus upgraded from Hold to Buy, price target set at $26.
  • PROG Holdings (PRG): Raymond James upgraded from Market Perform to Outperform, price target not specified.
  • Canadian Pacific Kansas City Ltd. (CP): Susquehanna upgraded from Neutral to Positive.

Downgrades

  • ATI Inc. (ATI): KeyBanc Capital Markets downgraded from Overweight to Sector Weight.
  • Avery Dennison (AVY): JP Morgan downgraded from Overweight to Neutral, price target lowered from $230 to $210.
  • Constellium (CSTM): Deutsche Bank downgraded from Buy to Hold, price target significantly reduced from $22 to $12.
  • Dyne Therapeutics (DYN): JP Morgan downgraded from Overweight to Neutral, price target decreased from $43 to $35.
  • Helix Energy (HLX): BTIG Research downgraded from Buy to Neutral.
  • Howmet Aerospace (HWM): KeyBanc Capital Markets downgraded from Overweight to Sector Weight.
  • ICON plc (ICLR): Robert W. Baird downgraded from Outperform to Neutral, price target not specified.
  • MAG Silver (MAG): ROTH MKM downgraded from Buy to Neutral, price target maintained at $17.
  • Seres Therapeutics (MCRB): JP Morgan downgraded from Neutral to Underweight.
  • OUTFRONT Media (OUT): Wolfe Research downgraded from Outperform to Peer Perform.
  • Verizon (VZ): KeyBanc Capital Markets downgraded from Overweight to Sector Weight.
  • U.S. Bancorp (USB): Deutsche Bank downgraded from Buy to Hold, price target not specified.
  • Stock Yards Bancorp (SYBT): Hovde Group downgraded from Outperform to Market Perform.
  • Autohome (ATHM): CLSA downgraded from Outperform to Hold.
  • Veritex Holdings (VBTX): Keefe Bruyette downgraded from Outperform to Market Perform.
  • L’Oreal (LRLCY): DZ Bank downgraded from Buy to Hold.
  • Michelin (MGDDY): HSBC Securities downgraded from Buy to Hold.
  • First Bancshares (FBMS): Janney downgraded from Buy to Neutral.
  • Noah Holdings (NOAH): UBS downgraded from Buy to Neutral.
  • LG Display (LPL): Citigroup downgraded from Buy to Sell.
  • Honeywell (HON): BofA Securities downgraded from Buy to Neutral, price target lowered from $250 to $230.
  • TKO Group Holdings (TKO): The Benchmark Company downgraded from Buy to Hold.
  • Coverage Initiated: Several companies were initiated with ratings and price targets, primarily by UBS and other firms.

October 23rd

Upgrades

  • Amylyx Pharmaceuticals (AMLX): BofA Securities upgraded from Neutral to Buy; PT raised from $4.2 to $10.
  • A.O. Smith (AOS): UBS upgraded from Sell to Neutral; PT raised from $75 to $80.
  • BXP, Inc. (BXP): Piper Sandler upgraded from Neutral to Overweight; PT raised from $78 to $105.
  • Quest Diagnostics (DGX): Robert W. Baird upgraded from Neutral to Outperform; PT raised from $157 to $182.
  • Snap (SNAP): JMP Securities upgraded from Market Perform to Market Outperform.
  • Texas Instruments (TXN): Summit Insights upgraded from Hold to Buy.
  • Alcoa (AA): Argus upgraded from Hold to Buy.
  • Adecco S.A. (AHEXY): Deutsche Bank upgraded from Hold to Buy.
  • Peapack-Gladstone Financial (PGC): Piper Sandler upgraded from Neutral to Overweight; PT raised from $30 to $35.

Downgrades

  • Ardmore Shipping (ASC): Stifel downgraded from Buy to Hold; PT lowered from $24 to $17.
  • CoStar Group (CSGP): RBC Capital Markets downgraded from Outperform to Sector Perform; PT lowered from $96 to $83.
  • Genco Shipping & Trading (GNK): Stifel downgraded from Buy to Hold; PT lowered from $26 to $17.
  • International Seaways (INSW): Stifel downgraded from Buy to Hold; PT lowered from $69 to $56.
  • Interpublic (IPG): Wells Fargo downgraded from Equal Weight to Underweight; PT lowered from $28 to $26.
  • McDonald’s (MCD): Robert W. Baird downgraded from Outperform to Neutral; PT lowered from $320 to $290. Guggenheim also downgraded from Buy to Neutral; PT lowered from $290 to $285.
  • Medpace (MEDP): Robert W. Baird downgraded from Outperform to Neutral; PT lowered from $413 to $349.
  • Star Bulk Carriers (SBLK): Stifel downgraded from Buy to Hold; PT lowered from $30 to $21.
  • Scorpio Tankers (STNG): Stifel downgraded from Buy to Hold; PT lowered from $90 to $65.
  • TFI International (TFII): Stifel downgraded from Buy to Hold; PT lowered from $158 to $142.
  • UP Fintech (TIGR): Citigroup downgraded from Buy to Sell; PT unchanged at $5.
  • Enphase Energy (ENPH): Multiple downgrades to Neutral and Sell.
  • A.O. Smith (AOS): DA Davidson downgraded from Buy to Neutral; PT unchanged at $80.
  • Alto Neuroscience (ANRO): Multiple downgrades to Neutral.

Coverage Initiated

  • Artivion (AORT): JMP Securities rated as Market Outperform; PT $33.
  • Coinbase Global (COIN): B. Riley Securities rated as Neutral; PT $185.
  • Corteva (CTVA): Citigroup rated as Buy; PT $68.
  • FMC Corp (FMC): Citigroup rated as Neutral; PT $67.
  • Gladstone (GLAD): B. Riley Securities rated as Neutral; PT $23.
  • Grab (GRAB): Daiwa Securities rated as Outperform; PT $4.6.
  • Disc Medicine (IRON): Jefferies rated as Buy; PT $89.
  • Oracle (ORCL): RBC Capital Markets rated as Sector Perform; PT $165.
  • Xos (XOS): ROTH MKM rated as Buy; PT $15.
  • Smurfit Westrock plc (SW): Citigroup rated as Buy; PT $57.
  • Charles River (CRL): CLSA rated as Underperform; PT $167.
  • Ferguson plc (FERG): Oppenheimer rated as Outperform; PT $234.

October 22nd

Upgrades

  • Aegon N.V. (AEG): UBS upgraded from Neutral to Buy.
  • Fluor (FLR): Citigroup upgraded from Neutral to Buy; price target increased from $52 to $65.
  • First Solar (FSLR): Citigroup upgraded from Neutral to Buy; price target increased from $200 to $254.
  • Paylocity (PCTY): Jefferies upgraded from Hold to Buy; price target increased from $145 to $200.
  • AMC Networks (AMCX): Seaport Research Partners upgraded from Neutral to Buy; no price target listed.
  • IAMGOLD (IAG): Canaccord Genuity upgraded from Hold to Buy.
  • Washington Trust (WASH): Piper Sandler upgraded from Underweight to Neutral; price target increased from $30 to $34.
  • 3M (MMM): Melius upgraded from Hold to Buy.

Downgrades

  • Canadian Solar (CSIQ): Citigroup downgraded from Neutral to Sell; price target decreased from $19 to $11.
  • Duke Energy (DUK): KeyBanc Capital Markets downgraded from Overweight to Sector Weight.
  • Global Payments (GPN): Bernstein downgraded from Outperform to Market Perform; price target decreased from $135 to $112.
  • Tecnoglass (TGLS): Raymond James downgraded from Strong Buy to Market Perform.
  • Coherent (COHR): Rosenblatt downgraded from Buy to Neutral; price target set at $105.
  • Gatos Silver (GATO): Canaccord Genuity downgraded from Buy to Hold.
  • Deckers Outdoor (DECK): BTIG Research downgraded from Buy to Neutral.
  • ING Groep (ING): Barclays downgraded from Overweight to Equal Weight.
  • Ping An Insurance (PNGAY): Jefferies downgraded from Buy to Hold.
  • AAON (AAON): Sidoti downgraded from Buy to Neutral; price target decreased from $102 to $111.
  • Snowflake (SNOW): Cleveland Research downgraded from Buy to Neutral.

New Coverage Initiated

  • Applied Industrial (AIT): Mizuho initiated coverage with Outperform; price target set at $285.
  • AppLovin (APP): Loop Capital initiated coverage with Buy; price target set at $181.
  • Braze (BRZE): Stifel initiated coverage with Buy; price target set at $37.
  • Cadence Design (CDNS): Mizuho initiated coverage with Outperform; price target set at $325.
  • Costco (COST): Bernstein initiated coverage with Outperform; price target set at $1016.
  • California Resources Corp (CRC): Stephens initiated coverage with Overweight; price target set at $73.
  • Contineum Therapeutics (CTNM): Robert W. Baird initiated coverage with Outperform; price target set at $32.
  • Dollar General (DG): Bernstein initiated coverage with Outperform; price target set at $98.
  • Dollar Tree (DLTR): Bernstein initiated coverage with Market Perform; price target set at $76.
  • Flex (FLEX): KeyBanc Capital Markets initiated coverage with Overweight; price target set at $41.
  • Home Depot (HD): Bernstein initiated coverage with Market Perform; price target set at $451.
  • Hershey Foods (HSY): Redburn Atlantic initiated coverage with Sell; price target set at $165.
  • Klaviyo (KVYO): Stifel initiated coverage with Buy; price target set at $45.
  • Lowe’s (LOW): Bernstein initiated coverage with Outperform; price target set at $323.
  • Mondelez Int’l (MDLZ): Redburn Atlantic initiated coverage with Buy; price target set at $82.
  • Insperity (NSP): JP Morgan initiated coverage with Underweight; price target set at $90.
  • Plexus (PLXS): KeyBanc Capital Markets initiated coverage with Sector Weight.
  • Synopsys (SNPS): Mizuho initiated coverage with Outperform; price target set at $650.
  • Target (TGT): Bernstein initiated coverage with Market Perform; price target set at $168.
  • Walmart (WMT): Bernstein initiated coverage with Outperform; price target set at $95.
  • Zeta Global (ZETA): KeyBanc Capital Markets initiated coverage with Overweight; price target set at $40.
  • Legacy Reserves (LGCY): Ladenburg Thalmann initiated coverage with Buy; price target set at $8.20.

October 21st

Upgrades

  • Albertsons (ACI): Melius upgraded from Hold to Buy; PT $24.
  • Ally Financial (ALLY): Raymond James upgraded from Underperform to Market Perform.
  • Healthpeak Properties (DOC): Deutsche Bank upgraded from Hold to Buy; PT raised from $20 to $28.
  • Gilead Sciences (GILD): Leerink Partners upgraded from Market Perform to Outperform; PT raised from $74 to $96.
  • GitLab (GTLB): Needham upgraded from Hold to Buy; PT $70.
  • Getty Realty Corp. (GTY): BofA upgraded from Neutral to Buy; PT raised from $31 to $34.
  • Home Bancorp (HBCP): Raymond James upgraded from Market Perform to Outperform; PT $50.
  • Independent Bank (INDB): Raymond James upgraded from Market Perform to Strong Buy; PT $74.
  • JD.com (JD): Loop Capital upgraded from Hold to Buy; PT decreased from $49 to $48.
  • Mid-America Apartment (MAA): Raymond James upgraded from Market Perform to Strong Buy; PT $175.
  • Mohawk (MHK): Robert W. Baird upgraded from Neutral to Outperform; PT raised from $160 to $196.
  • NexPoint Residential (NXRT): Raymond James upgraded from Market Perform to Outperform; PT $50.
  • RH (RH): Wedbush upgraded from Neutral to Outperform; PT $430.
  • Simmons First National (SFNC): Stephens upgraded from Equal-Weight to Overweight; PT raised from $27 to $28.
  • Sportradar Group AG (SRAD): JP Morgan upgraded from Neutral to Overweight; PT raised from $12 to $15.
  • Travere Therapeutics (TVTX): Wells Fargo upgraded from Equal Weight to Overweight; PT raised from $9 to $27.
  • Volvo (VLVLY): Stifel upgraded from Hold to Buy.
  • Warby Parker (WRBY): Goldman upgraded from Neutral to Buy; PT raised from $15 to $18.
  • Gentherm (THRM): JP Morgan upgraded from Underweight to Neutral; PT $56.

Downgrades

  • Centerspace (CSR): Raymond James downgraded from Outperform to Market Perform.
  • Essex Property (ESS): Raymond James downgraded from Outperform to Market Perform.
  • Extra Space Storage (EXR): Wells Fargo downgraded from Overweight to Equal Weight; PT $175.
  • Canada Goose (GOOS): Goldman downgraded from Neutral to Sell; PT lowered from $11.5 to $9.
  • HCI Group (HCI): Compass Point downgraded from Buy to Neutral; PT $119.
  • Hilton (HLT): Melius downgraded from Buy to Hold.
  • MDU Resources (MDU): BofA downgraded from Buy to Neutral; PT raised from $30 to $31.
  • ServiceNow (NOW): Morgan Stanley downgraded from Overweight to Equal-Weight; PT raised from $900 to $960.
  • Old Dominion (ODFL): Stifel downgraded from Buy to Hold; PT lowered from $209 to $197.
  • Prologis (PLD): Goldman downgraded from Buy to Neutral; PT lowered from $142 to $132.
  • Piedmont Lithium (PLL): JP Morgan downgraded from Neutral to Underweight; PT $9 to $8.
  • Rexford Industrial Realty (REXR): BofA downgraded from Buy to Neutral; PT lowered from $66 to $49.
  • Saia (SAIA): Stifel downgraded from Buy to Hold; PT lowered from $440 to $437.
  • SolarEdge Technologies (SEDG): TD Cowen downgraded from Buy to Hold; PT lowered from $35 to $16.
  • Trinity Industries (TRN): Susquehanna downgraded from Positive to Neutral; PT $34 to $35.
  • UPS (UPS): Barclays downgraded from Equal Weight to Underweight; PT $120.
  • WaFd, Inc. (WAFD): Keefe Bruyette downgraded from Outperform to Market Perform; PT $40.
  • Hertz Global (HTZ): JP Morgan downgraded from Neutral to Underweight.
  • Kering SA (PPRUY): Citigroup downgraded from Buy to Neutral.
  • Munich Re (MURGY): Jefferies downgraded from Buy to Hold.
  • SGS SA (SGSOY): RBC Capital Markets downgraded from Sector Perform to Underperform.
  • Intertek Group (IKTSY): RBC Capital Markets downgraded from Outperform to Sector Perform.
  • Petrobras (PBR): HSBC Securities downgraded from Buy to Hold.

Coverage Initiated

  • BioAge Labs (BIOA): Morgan Stanley with Overweight; PT $40. Jefferies with Buy; PT $42.
  • BKV Corporation (BKV): Barclays with Overweight; PT $24. Mizuho with Outperform; PT $29. KeyBanc Capital Markets with Overweight; PT $23. Jefferies with Buy; PT $28. Evercore ISI with Outperform; PT $24. Citigroup with Buy; PT $29.
  • Capricor Therapeutics (CAPR): Piper Sandler with Overweight; PT $35.
  • Elme Communities (ELME): Wolfe Research with Peer Perform.
  • Esco Tech (ESE): The Benchmark Company with Buy; PT $150.
  • GE Vernova (GEV): Deutsche Bank with Buy; PT $354.
  • Guardian Pharmacy Services (GRDN): Truist with Buy; PT $22. Raymond James with Outperform; PT $21.
  • Similarweb (SMWB): Needham with Buy; PT $11.
  • INmune Bio (INMB): Alliance Global Partners with Buy; PT $20.
  • Arcus Biosciences (RCUS): H.C. Wainwright with Neutral; PT $20.
  • Hormel Foods (HRL): Exane BNP Paribas with Underperform; PT $28.
  • Korro Bio (KRRO): Raymond James with Strong Buy; PT $153.
  • Rhythm Pharmaceuticals (RYTM): Guggenheim with Buy; PT $70.
  • Sarepta Therapeutics (SRPT): Jefferies with Buy; PT $165.
  • Alaska Air (ALK): Barclays with Overweight; PT $55.
  • CyberArk (CYBR): Scotiabank with Sector Outperform; PT $340.
  • Perfect Corp. (PERF): Noble Capital Markets with Outperform; PT $5.